Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 17, 2020 11:31 PM 5 min read

Embolic Protection Devices Market 2019: Size, Share, Demands, Growth, Opportunities, Trends Analysis and Forecast Till 2027

by COMSERVE
Follow

New York, United States, Wed, 18 Nov 2020 04:31:56 / Comserve Inc. / -- The global embolic protection devices market is anticipated to record a CAGR of around 9% over the forecast period i.e. 2019-2027

The report titled "Embolic Protection Devices Market: Global Demand Analysis & Opportunity Outlook 2027"delivers detailed overview of the global embolic protection devices market in terms of market segmentation by product, application, end user and region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model.

According to WHO 17.9 million people die globally each year from cardiovascular disease which accounts for 31% of all deaths worldwide.

The capability of the system to reduce the debris release into the blood stream and small vessels in case of cardiovascular disease has increased the demand for embolic protection devices. These devices tend to reduce complication rates during carotid and saphenous vein graft procedures. One of the major use is to remove plague debris at time of trans catheter aortic valve replacement owing to which the recent expansion in the industry is expected to support the market growth for global embolic protection market. The global embolic protection devices market is anticipated to record a CAGR of around 9% over the forecast period i.e. 2019-2027 owing to increasing neurovascular, cardiovascular and peripheral disease cases coupled with the growing demand for protection of brain in case of embolization and various government initiatives.

The Final Report will cover the impact analysis of COVID-19 on this industry: https://www.researchnester.com/sample-request-2115

The market is segmented by product, by application and by end user. The product segment is further segmented into distal occlusion filters, proximal occlusion filters and distal filters out of which, the distal occlusion filters segment is anticipated to have highest CAGR during the forecast period on the back of benefits offered by the product. For instance, prevention of embolization via balloon occlusion, low crossing profile and others. This is followed by distal filters segment which is expected to witness strong CAGR owing to broad variety of specifications, filter details, crossing profile, landing zone length and pore size. On the basis of application, the market is segmented into neurovascular, cardio vascular and peripheral vascular, out of which the cardiovascular segment is expected to have leading shares on account of rising geriatric population and increasing cardio vascular disease cases owing to unhealthy lifestyle and improper eating habits followed by peripheral vascular segment and neurovascular segment. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers and others, out of which, hospitals are estimated to have leading share on the back of increasing angioplasty procedures coupled with rise in government initiatives to provide better health care facilities and improved reimbursement policies.

Geographically, the global embolic protection devices market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. The market in North America is anticipated to leading market share on the back of rise in demand minimal invasive products, technological advancements and presence of key market players coupled with rising geriatric population and government initiatives in healthcare sector. The market in Europe is expected to have second largest market share owing to huge healthcare expenditure capability, availability of better healthcare facilities and growing healthcare infrastructure. On the other hand, the market in Asia-Pacific expected to witness highest market growth on the account of increasing healthcare awareness, rising population, availability of better healthcare facilities and improvement in standard of living.

Request For Full Report @ https://www.researchnester.com/sample-request-2115

Growing Rate of Cardiac Diseases to Boost the Demand for Embolic Protection

The growing rate of cardiac disease owing to rising geriatric and increasing inclination of the population towards unhealthy lifestyle coupled with the expansion in global trans-catheter aortic valve replacement market are expected to drive the market growth.

Industry Players are Progressing towards Minimizing the Barriers faced by the Global Embolic Protection Market

The high cost associated with the use of embolic protection system and product failures coupled with presence of better alternatives are expected to operate as key restraints to the growth of global embolic protection market over the forecast period.

Read More About This Report@ https://www.researchnester.com/reports/embolic-protection-devices-market/2115

For more information, please contact:

AJ Daniel

Research Nester
Email: [email protected]
Tel: +1-6465869123

The post Embolic Protection Devices Market 2019: Size, Share, Demands, Growth, Opportunities, Trends Analysis and Forecast Till 2027 appeared first on Comserveonline.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


ABT Logo
ABTAbbott Laboratories
$112.30-0.34%
Overview
BSX Logo
BSXBoston Scientific Corp
$74.72-0.01%
EW Logo
EWEdwards Lifesciences Corp
$75.87-%
MDT Logo
MDTMedtronic PLC
$99.500.01%

This report also provides the existing competitive scenario of some of the key players of the global embolic protection market which includes company profiling of Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Transverse Medical, Inc, Medtronic Plc (NYSE:MDT), Edward Lifesciences (NYSE:EW), Innovative Cardiovascular Solutions, Claret Medical, Inc., Gore Medical and other prominent players.

The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global embolic proetection market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.

ABT Logo
ABTAbbott Laboratories
$112.30-0.34%
Overview
BSX Logo
BSXBoston Scientific Corp
$74.72-0.01%
EW Logo
EWEdwards Lifesciences Corp
$75.87-%
MDT Logo
MDTMedtronic PLC
$99.500.01%
Comments
Loading...